1. Home
  2. IMNN vs RAY Comparison

IMNN vs RAY Comparison

Compare IMNN & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$2.67

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Logo Raytech Holding Limited Ordinary Shares

RAY

Raytech Holding Limited Ordinary Shares

HOLD

Current Price

$3.69

Market Cap

10.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNN
RAY
Founded
1982
1993
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
10.8M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
IMNN
RAY
Price
$2.67
$3.69
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
32.8K
10.0K
Earning Date
05-14-2026
07-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.84
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.15
52 Week High
$9.32
$5.49

Technical Indicators

Market Signals
Indicator
IMNN
RAY
Relative Strength Index (RSI) 34.66 63.01
Support Level $2.59 $3.24
Resistance Level $3.24 $3.68
Average True Range (ATR) 0.17 0.26
MACD -0.01 0.17
Stochastic Oscillator 8.11 88.41

Price Performance

Historical Comparison
IMNN
RAY

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About RAY Raytech Holding Limited Ordinary Shares

Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.

Share on Social Networks: